COMPOUNDS, COMPOSITIONS AND METHODS OF TREATMENT THEREOF

The present disclosure relates to treatment of a subject who has been identified with an increased A2A expression or density of A2AR+ cells. La présente divulgation concerne le traitement d'un sujet ayant été identifié comme présentant une expression ou une densité accrue de cellules A2A ou A2A...

Full description

Saved in:
Bibliographic Details
Main Authors SRIVASTAVA, Shouraydeep, ROSS, Sally, MARTINOLI, Chiara, WALD, Noemie, LAGER, Joanne
Format Patent
LanguageEnglish
French
Published 25.08.2022
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
ENZYMOLOGY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROCESSES OF PREPARING SUCH COMPOSITIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates to treatment of a subject who has been identified with an increased A2A expression or density of A2AR+ cells. La présente divulgation concerne le traitement d'un sujet ayant été identifié comme présentant une expression ou une densité accrue de cellules A2A ou A2AR+.
Bibliography:Application Number: WO2022US16808